For PRDM1 in colon cancer, Kim et al. reported that it promotes chemoresistance [25], Liu et al. reported that it inhibits proliferation [27], and Wan et al. reported that it induces cell cycle arrest [49]. Here, PRDM1 is linked to malignant colon neoplasm.